Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 5, 2010, Pages 374-386

  Xiao, Yanling ^a,b   Peperzak, Victor ^b   Van Rijn, Linda ^a   Borst, Jannie ^b   De Bruijn, Joost D ^a,c  

^a Progentix BV   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dexamethasone; Differentiation; Expansion; Gene profiling; Mesenchymal stem cell; Multipotency; Senescence

Indexed keywords

CELL DEATH; CELL MEMBRANES; CELL PROLIFERATION; EXPANSION; STEM CELLS; TRANSCRIPTION;

BONE MARROW MESENCHYMAL; DEXAMETHASONES; DIFFERENTIATION; EXPANSION PHASE; GENE PROFILING; HUMAN MESENCHYMAL STEM CELLS; LOW DOSE; MESENCHYMAL STEM CELL; MULTIPOTENCY; SENESCENCE;

CELL CULTURE;

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; DEXAMETHASONE; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN;

ADIPOGENESIS; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL EXPANSION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 77954276912     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.250     Document Type: Article

References (54)

1. Aggarwal S, Pittenger MF. 2005; Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
2. Awad HA, Halvorsen YD, Gimble JM, et al. 2003; Effects of TGFβ1 and dexamethasone on the growth and chondrogenic differentiation of adipose derived stromal cells. Tissue Eng 9: 1301-1312.
3. Both SK, van der Muijsenberg AJ, van Blitterswijk CA, et al. 2007; A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 13: 3-9. (Pubitemid 46175525)
4. Bruder SP, Kurth AA, Shea M, et al. 1998; Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16: 155-162. (Pubitemid 28249153)
5. Caplan AI. 1994; The mesengenic process. Clin Plastic Surg 21(3): 429-435.
6. Chang JK, Ho ML, Yeh CH, et al. 2006; Osteogenic gene expression decreases in stromal cells of patients with osteonecrosis. Clin Orthop 453: 286-292.
7. Cheng SL, Yang JW, Rifas L, et al. 1994; Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286.
8. Cosio BG, Torrego A, Adcock IM. 2005; Molecular mechanisms of glucocorticoids. Arch Bronconeumol 41: 34-41.
9. Cosio BG, Torrego A, Adcock IM. 2005; Molecular mechanisms of glucocorticoids. Arch Bronconeumol 41: 34-41.
10. De Kok IJ, Peter SJ, Archambault M, et al. 2003; Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: preliminary findings. Clin Oral Implants Res 14: 481-489.
11. Di Niccola M, Carlo-Stella C, Magni M, et al. 2002; Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
12. D'Ippolito G, Diabira S, Howard GA, et al. 2006; Low oxygen tension inhibits osteogenic differentiation and enhances stemness of MIAMI cells. Bone 39: 513-522.
13. Doi M, Nagano A, Nakamura Y. 2002; Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem Biophys Res Comm 290: 381-390.
14. Giembycz MA, Lindsay MA. 1999; Pharmacology of the eosinophil. Pharmacol Rev 51: 213-339.
15. Hendriks J, Riesle J, van Blitterswijk AC. 2006; The effect of stratified cultured compared to confluent culture in monolayer on proliferation and differentiation of human articular chondrocytes. Tissue Eng 12: 2397-2405. (Pubitemid 46141265)
16. Hong L, Sultana H, Paulius K, et al. 2009; Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference. J Steroid Biochem Mol Biol 114: 180-185.
17. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. 1999; Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309-313.
18. Horwitz EM, Gordon PL, Koo WK, et al. 2002; Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99: 8932-8937.
19. Kawada H, Fujita J, Kinjo K, et al. 2004; Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581-3587.
20. Martin I, Muraglia A, Campanile G, et al. 1997; Fibroblast growth factor-2 supports ex vivo expansion andmainterance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462. (Pubitemid 27408494)
21. Koc ON, Gerson SL, Cooper BW, et al. 2000; Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-316.
22. Krampera M, Glennie S, Dyson J, et al. 2003; Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729. (Pubitemid 36857965)
23. Le Blanc K, Rasmusson I, Sundberg B, et al. 2004; Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441. (Pubitemid 38586721)
24. Lee KD, Kuo TK, Whang-Peng J, et al. 2004; In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284.
25. Liechty KW, MacKenzie TC, Shaaban AF, et al. 2000; Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6: 1282-1286.
26. Mendes SC, Tibbe JM, Veenhof K, et al. 2002; Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8: 911-920.
27. Muraglia A, Cancedda R, Quarto R. 2000; Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113: 1161-1166. (Pubitemid 30229533)
28. Newton R. 2000; Molecular mechanisms of glucocoticoid action: what is important? Thorax 55: 603-613.
29. Petit PX, Lecoeur H, Zorn E, et al. 1995; Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130: 157-167.
30. Phinney DG, Kopen G, Righter W, et al. 1999; Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436. (Pubitemid 29521651)
31. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
32. Pittenger MF, Mbalaviele G, Black M, et al. 2001; Mesenchymal stem cells. In Human Cell Culture, Koller MR, Palsson BO, Master JRW (eds). Kluwer Academic: Amsterdam, 2001 Chapter 9.
33. Pittenger MF, Martin BJ. 2004; Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20. (Pubitemid 38931831)
34. Prockop DJ. 1997; Marrow stromal cells as stem cells of nonhematopoietic tissue. Science 276: 71-74. (Pubitemid 27161245)
35. Pulaski L, Kania K, Ratajewski M, et al. 2005; Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids. J Steroid Biochem Mol Biol 96: 229-234. (Pubitemid 41080503)
36. Shim WSN, Tan GMY, Wong P. 2005; Cardiac differentiated adult human bone marrow stem cells express sarcomeric and structural proteins of cardiomyocytes. Microsc Microanal 11(suppl 2): 912-913.
37. Siddappa R, Licht R, van Blitterswijk CA, et al. 2007; Donor variation and loss of multipotency of human mesenchymal stem cells during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25: 1029-1041. (Pubitemid 47233079)
38. Smith RK, Webbon PM. 2005; Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med 39: 582-584.
39. Stenderup K, Justesen J, Clausen C, et al. 2003; Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-920.
40. Song L, Webb NE, Song YJ, et al. 2006; Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 24: 1707-1708.
41. Song IH, Caplan AI, Dennis JE. 2009; Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res 27: 216-221.
42. Stolzing A, Coleman N, Scutt A. 2006; Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 9: 31-35.
43. Stute N, Holtz K, Bubenheim M, et al. 2004; Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32: 1212-1225.
44. Timper K, Seboek D, Eberhardt M, et al. 2006; Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341: 1135-1140.
45. Toma C, Pittenger MF, Cahill KS, et al. 2002; Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
46. Wakitani S, Goto T, Pineda SJ, et al. 1994; Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76: 579-592.
47. Wakitani S, Saito T, Caplan AI. 1995; Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426.
48. Woodbury D, Schwarz EJ, Prockop DJ, et al. 2000; Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364-370.
49. Walsh S, Jordan GR, Jefferiss C, et al. 2001; High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology 40: 74-83.
50. Wang GJ, Cui Q, Balian G. 2000; The Nicolas Andry Award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop 370: 295-310.
51. Wen LP, Madani K, Fahrni JA, et al. 1997; Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. Am J Physiol Lung Cell Mol Physiol 273: L921-929.
52. Xu FH, Sharma S, Gardner A, et al. 1998; Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 92: 241-251.
53. Zulewski H. 2006; Stem cells with potential to generate insulin-producing cells in man. Swiss Med Wkly 136: 647-654.
54. Zuk PA, Zhu M, Ashjian P, et al. 2002; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.